MOTS-c 40mg Research Peptide Australia
MOTS-c 40mg is a strength-specific mitochondrial-derived peptide research presentation supplied by Australian Peptide for laboratory, analytical and in-vitro scientific investigation. This listing represents one vial containing 40mg nominal MOTS-c research material.
The 40mg product is maintained separately from the existing MOTS-c 10mg listing so researchers can distinguish the vial quantity, SKU, batch identifier and applicable analytical documentation without relying on a generic MOTS-c record.
Looking to buy MOTS-c 40mg in Australia for laboratory research? Australian Peptide supplies this research presentation with Australian dispatch and batch-specific documentation required for the active sale batch. It is not intended for human, veterinary, therapeutic, cosmetic or personal use.
Key Features
- MOTS-c 40mg research presentation
- Mitochondrial-derived peptide
- 16-amino-acid peptide
- Lyophilised research material
- Strength-specific product and batch record
- Batch-specific Janoshik COA required before sale
- Australian dispatch
Product Specifications
Product Name: MOTS-c
Full Name: Mitochondrial Open Reading Frame of the 12S rRNA-c
Nominal Content: 40mg
Quantity: 1 vial
Physical Form: Lyophilised powder
Research Category: Mitochondrial-derived peptide
Country of Dispatch: Australia
What Is MOTS-c?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame within the mitochondrial 12S rRNA region. Its discovery expanded research into mitochondria-derived signalling peptides and mitochondria-to-nucleus communication.
Experimental work has investigated MOTS-c in cellular metabolism, energetic stress responses and AMPK-linked signalling. Early mechanistic studies in cells and animal models examined interactions with the folate-purine pathway, accumulation of AICAR and activation of AMP-activated protein kinase.
Human research has also measured endogenous MOTS-c in circulation and skeletal muscle, including changes associated with exercise physiology. Those observations do not establish the safety or efficacy of exogenous MOTS-c as a treatment. Much of the intervention evidence remains preclinical.
For a deeper scientific overview, see Understanding MOTS-c in Modern Biochemistry Literature.
What the 40mg Label Means
The 40mg designation identifies the nominal quantity of MOTS-c research material associated with the vial. It does not by itself define chromatographic purity, concentration after laboratory preparation, biological activity or any universal experimental protocol.
Mass and concentration are separate variables. For general laboratory terminology, see What Does mg Mean on a Peptide Vial? and the Peptide Concentration Guide.
MOTS-c 40mg vs MOTS-c 10mg
The peptide identity remains MOTS-c across the two Australian Peptide presentations. The difference is the nominal amount supplied in the vial. The existing MOTS-c 10mg Research Peptide contains a lower labelled mass, while this listing represents the 40mg presentation.
Keeping the strengths as separate product records improves catalogue clarity and helps laboratories match the correct vial quantity with the correct batch-specific documentation.
Certificate of Analysis and Batch Verification
Australian Peptide requires batch-specific analytical documentation for the active sale batch. Researchers should match the batch identifier printed on the vial with the corresponding Janoshik record before analytical results are incorporated into laboratory documentation.
A high purity percentage and a 40mg quantity claim answer different analytical questions. Purity describes the relative composition detected by a method such as HPLC; quantity describes how much material is present. The applicable COA should therefore be read carefully rather than treating one number as proof of every product attribute.
Current batch records can be reviewed through the COA Library. Learn more through Quality Assurance, Certificate of Analysis Explained and Research Peptide Quality Standards.
Storage and Research Handling
Peptide stability is affected by temperature, moisture, light, repeated handling and the specific solution conditions used in a validated method. Keep sealed lyophilised material protected from unnecessary heat, light and moisture, and follow the applicable batch or laboratory documentation.
Australian Peptide does not present one universal post-preparation storage window for every peptide or concentration. For general principles, see Laboratory Storage of Research Peptides.
Research Tools and Related Products
Researchers comparing mass and concentration can use the Peptide Reconstitution Calculator as a mathematical laboratory reference tool. It does not provide dosing or therapeutic advice.
For the lower-strength presentation, see MOTS-c 10mg Research Peptide. Browse the full Research Peptides collection for other batch-identified research materials.
Frequently Asked Questions
Where can laboratories buy MOTS-c 40mg in Australia?
Australian Peptide supplies MOTS-c 40mg online in Australia for lawful laboratory and analytical research, with Australian dispatch and matching batch documentation required for the active sale batch.
What is MOTS-c?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region and studied in mitochondrial signalling and cellular metabolism research.
What does 40mg mean?
It identifies the nominal amount of research material associated with the vial. It is separate from analytical purity and from any solution concentration prepared during laboratory work.
Does the 40mg strength make MOTS-c a different compound?
No. The compound identity remains MOTS-c. The strength-specific listing identifies the quantity supplied and the batch documentation associated with that presentation.
What does the published research show?
Published research includes cell, animal and human physiology observations involving metabolic signalling, AMPK-related pathways and exercise responses. Much of the intervention evidence remains preclinical, so findings need to be interpreted within the model studied.
Is this product intended for human use?
No. It is supplied strictly for lawful laboratory, analytical and in-vitro research. No dosing, administration or therapeutic guidance is provided.
Australian Peptide Research Standards
Australian Peptide supplies research materials with an emphasis on clear product identification, batch traceability and accessible analytical documentation. Active peptide batches are required to have batch-specific documentation that matches the material being supplied.
- Australian dispatch
- Batch-specific analytical documentation
- Janoshik Certificate of Analysis required for the active sale batch
- COA Library access and batch traceability
- Research-focused product information
- Price Match Guarantee for eligible comparable Australian listings
Current retail promotions, multi-vial savings, complimentary-vial eligibility and shipping offers are applied according to the terms displayed on the website and at checkout.
Related MOTS-C Research Guide
Read our MOTS-C 10mg vs 40mg research comparison for a detailed explanation of mass, concentration, HPLC purity, LC-MS identity and batch documentation.
